$HALO News Article - Positive Topline Data Reported from argenx's ADHERE Study of VYVGART Hytrulo with Halozyme's ENHANZE Drug Delivery Technology in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
https://marketwirenews.com/news-releases/posi...40067.html